← Leaderboards
Dan Feng
Confometrx, Inc.
$2,524,550
Attributed
$4,478,807
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $676.1K · FY2010–21$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,478,807 · 4
By mechanism
R44$3,785,122 · 2
R43$693,685 · 2
Top collaborators
- Inbar Fish5 shared
- Bingfa Sun5 shared
- Victoria Ahn1 shared
Most similar at Confometrx, Inc.
Same institution · by research overlap
- Bingfa Sun$4,003,184
- Inbar Fish$1,649,318
- Victoria Ahn$817,454
- Matthew Chu$124,502
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseSmall Business Innovation Research GrantG-Protein-Coupled ReceptorsPharmaceutical PreparationsThree Dimensional StructureCrystallizationBrainSmall MoleculeReceptorProteinsStructureSchizophreniaResponseDrug DiscoveryAgonistBaseMental DepressionMental DisordersMental HealthPlayNervous System DisorderFamilyResolutionLead
Grant awards (11)
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$676,062
R44 · FY2021 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$676,062
R44 · FY2020 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$676,062
R44 · FY2019 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$381,468
R44 · FY2018 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$376,468
R44 · FY2017 · MH
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands$193,685
R43 · FY2017 · MH
DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS$333,000
R44 · FY2014 · MH · contact PI
DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS$333,000
R44 · FY2013 · MH · contact PI
DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS$333,000
R44 · FY2012 · MH · contact PI
DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS$250,000
R43 · FY2011 · MH · contact PI
DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS$250,000
R43 · FY2010 · MH · contact PI